Skip to Main Content

Author Details

Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
0000-0002-3700-0480
1990
83
37
PMIDPaper TitleJournal TitlePublished Year
36900358Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth.Cancers (Basel)2023
34312396Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.NPJ Breast Cancer2021
34273100Building Capacity for Global Cancer Research: Existing Opportunities and Future Directions.J Cancer Educ2021
34292501Project ECHO Cancer Initiative: a Tool to Improve Care and Increase Capacity Along the Continuum of Cancer Care.J Cancer Educ2021
30629457Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics.J Glob Oncol2019
31798764John Mendelsohn: A visionary scientist, oncologist and leader.Genes Cancer2019
29092024Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.Ann Oncol2018
29708544Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System.J Vis Exp2018
28344040m<sup>6</sup>A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.Cancer Cell2017
26861698Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.J Transl Med2016
25302990Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.Int J Cancer2015
25795775A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.J Biol Chem2015
25410762Radiation-induced autophagy contributes to cell death and induces apoptosis partly in malignant glioma cells.Cancer Res Treat2015
24889208Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center.J Surg Oncol2014
22729867Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.Int J Cancer2013
23885787Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.BMC Genomics2013
23393598The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.PLoS One2013
23250739Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of οEGFR/EGFRvIII.J Biol Chem2013
23359207Regulation of HGF expression by οEGFR-mediated c-Met activation in glioblastoma cells.Neoplasia2013
21866566Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.J Cell Biochem2012
22753228Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Neuro Oncol2012
20473884Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.Int J Cancer2011
21775422Forced dimerization increases the activity of οEGFR/EGFRvIII and enhances its oncogenicity.Mol Cancer Res2011
21968439A simple guide screw method for intracranial xenograft studies in mice.J Vis Exp2011
21908708Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.Mol Pharmacol2011
21183793Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.J Clin Invest2011
21214269Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of οEGFR.J Proteome Res2011
20551902CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice.EMBO J2010
20713409The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.Neuro Oncol2010
19048625Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.Int J Cancer2009
19920199Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.Cancer Res2009
19270491Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity.Autophagy2009
18259115Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.Autophagy2008
19115005Exploratory analysis of the copy number alterations in glioblastoma multiforme.PLoS One2008
18501776Proteomics: the new frontier also for brain tumor research.Curr Probl Cancer2008
18501773Biomarkers and cancer stem cells in primary brain tumors. Foreword.Curr Probl Cancer2008
16978157Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.Biochem J2007
17369861Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.Oncogene2007
17264672Proteomic comparison of oligodendrogliomas with and without 1pLOH.Cancer Biol Ther2007
15951525Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles.Mol Cell Proteomics2006
16723633Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.Neuro Oncol2006
16899617Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.Clin Cancer Res2006
15557335Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities.J Biol Chem2005
16052525Angiogenesis and apoptosis in glioma: two arenas for promising new therapies.J Cell Biochem2005
15048881Proliferation marker pKi-67 occurs in different isoforms with various cellular effects.J Cell Biochem2004
15522216Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies.Biochem Biophys Res Commun2004
15456872Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.Mol Cell Biol2004
12474222The proliferation marker pKi-67 organizes the nucleolus during the cell cycle depending on Ran and cyclin B.J Pathol2003
14697673Constitutive EGFR signaling confers a motile phenotype to neural stem cells.Mol Cell Neurosci2003
12934086International Hermelin Brain Tumor Center Symposium on Apoptosis.Cell Death Differ2003
  • 1 - 50 of 83

Recommended Authors

University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 2
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 7
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 2
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 5
Lerner Research Institute, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 13
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year 1999
Number of shared co-authors 2
Virginia Commonwealthy University
Career Start Year 1998
Number of shared co-authors 2
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center
Career Start Year 1998
Number of shared co-authors 2
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 3
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 15
Erasmus MC Cancer Institute
Career Start Year 1995
Number of shared co-authors 7
Stanford University
Career Start Year 1994
Number of shared co-authors 9
Indiana University School of Medicine
Career Start Year 1994
Number of shared co-authors 1
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Career Start Year 1993
Number of shared co-authors 9
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 13
Northwestern University
Career Start Year 1992
Number of shared co-authors 5
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 11
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 29
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 25
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 40
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 7
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 1985
Number of shared co-authors 4
University of California san francisco
Career Start Year 1985
Number of shared co-authors 15
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 16
Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 1
IRCCS San Raffaele Scientific Institute
Career Start Year 1983
Number of shared co-authors 21
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 15
University of California san francisco
Career Start Year 1975
Number of shared co-authors 16
Mount Sinai Hospital
Career Start Year 1943
Number of shared co-authors 7

Collaborators

Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 11
Institute of Anatomy, Technische Universitat Dresden School of Medicine
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 8
University of Rochester Medical Center
Co-authored papers 8
Ontario Brain Institute
Co-authored papers 8
University of California San Diego
Co-authored papers 7
Moffitt Cancer Center
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Regeneron Pharmaceuticals Inc.
Co-authored papers 6
National Cancer Institute
Co-authored papers 6
MD Anderson Cancer Center
Co-authored papers 5
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 5
Virginia Commonwealth University, United States of America Massey Cancer Center
Co-authored papers 5
Henry Ford Hospital
Co-authored papers 5
National Institute of Allergy and Infectious Disease, National Institutes of Health
Co-authored papers 5
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Kumamoto University Hospital
Co-authored papers 4
Fukuoka University
Co-authored papers 4
Henry Ford Hospital
Co-authored papers 4
Co-authored papers 4
Henry Ford Hospital
Co-authored papers 4
Frimley Health NHS Foundation Trust
Co-authored papers 3
Institute of Biochemistry II, Goethe University Frankfurt
Co-authored papers 3
George Washington University
Co-authored papers 3
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
Mahidol University
Co-authored papers 3
University of Glasgow, University Place
Co-authored papers 3
MD Anderson Cancer Center
Co-authored papers 3
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
University of Texas M.D. Anderson Cancer Center
Co-authored papers 3